5 products were found matching "K25001"!

No results were found for the filter!
Punicalin
Punicalin

Item number: TGM-T4S1718-100mg

Description: Punicalin exerts anti-inflammatory, antioxidative, and anti-hepatotoxic activities, it shows inhibitory activity on HIV-1 reverse transcriptase in a dose-dependent manner, with an IC50 of 0.11 microg/ml (0.14 microM). Target: HIV Protease, HBV. Smiles:...
Application: Bioactive ellagitannin
CAS 65995-64-4
MW: 782.53 D
From 43.00€ *
Review
Punicalin
Punicalin

Item number: Cay33714-1

Punicalin is an ellagitannin that has been found in P. granatum and has diverse biological activities. It inhibits the interaction between the severe acute respiratory coronavirus 2 (SARS-CoV-2) spike glycoprotein receptor-binding domain (RBD), also known as the surface glycoprotein RBD, and angiotensin-converting...
Keywords: cyclic...
Application: Bioactive ellagitannin
CAS 65995-64-4
MW: 782.5 D
From 85.00€ *
Review
Withanone
Withanone

Item number: Cay11804-1

Withanone is a phytochemical that has been found in W. somnifera and has diverse biological activities. It inhibits the protein-protein interaction between human angiotensin-converting enzyme 2 (ACE2) and the SARS-CoV-2 spike protein receptor-binding domain (IC50 = 0.33 ng/ml). Withanone (10 µg/ml) protects against...
Keywords: NSC 179884, 6alpha,7alpha-epoxy-5alpha,17,22R-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid, delta-lactone
Application: Bioactive phytochemical
CAS 27570-38-3
MW: 470.6 D
From 116.00€ *
Review
Tixagevimab
Tixagevimab

Item number: TGM-T76976-5mg

Description: Tixagevimab (AZD8895) is a human monoclonal antibody that targets the receptor binding domain (RBD) of SARS-CoV-2, neutralizing the virus by preventing the S-glycoprotein from binding to its receptor through attachment to the RBD and the S-glycoprotein ectodomain [1].
Application: Targets SARS coronavirus spike protein S1 (S1)
CAS 2420564-02-7
Please request pricing for this article.
Review
Cilgavimab
Cilgavimab

Item number: TGM-T76999-5mg

Description: Cilgavimab (AZD-1061, COV2-2130), a humanized SARS-CoV-2-neutralizing monoclonal antibody, is part of the monoclonal antibody combination AZD7442 with Tixagevimab and demonstrates protective effects in mouse models of SARS-CoV-2 infection [1].
Application: Targets SARS coronavirus spike protein S1 (S1)
CAS 2420563-99-9
Please request pricing for this article.
Review